
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $777.6M | -- | -- | $3.84 | -- |
07/30/2025 | Q2 | $751.6M | -- | -- | $3.49 | -- |
04/28/2025 | Q1 | $719.7M | $731.1M | $2.48 | $3.11 | -$0.63 |
01/28/2025 | Q4 | $716.5M | $766.5M | $2.82 | $3.38 | -$0.56 |
10/28/2024 | Q3 | $730.6M | $746.7M | $2.80 | $3.45 | -$0.65 |
07/29/2024 | Q2 | $686M | $695.5M | $2.44 | $2.97 | -$0.53 |
04/29/2024 | Q1 | $684.3M | $681.4M | $2.00 | $2.87 | -$0.87 |
01/29/2024 | Q4 | $685.1M | $692.6M | $2.32 | $3.04 | -$0.72 |
10/24/2023 | Q3 | -- | -- | $2.55 | $3.21 | -$0.66 |
07/24/2023 | Q2 | -- | -- | $1.48 | $2.86 | -$1.38 |
04/19/2023 | Q1 | -- | -- | $1.34 | $2.42 | -$1.08 |
01/24/2023 | Q4 | -- | -- | $1.20 | $2.33 | -$1.13 |
10/25/2022 | Q3 | -- | -- | $1.49 | $2.51 | -$1.02 |
07/25/2022 | Q2 | -- | -- | $1.37 | $2.23 | -$0.86 |
04/26/2022 | Q1 | -- | -- | $0.92 | $2.01 | -$1.09 |
01/25/2022 | Q4 | -- | -- | $1.51 | $2.78 | -$1.27 |
10/26/2021 | Q3 | -- | -- | $1.80 | $2.75 | -$0.95 |
07/26/2021 | Q2 | -- | -- | $1.46 | $2.46 | -$1.00 |
04/27/2021 | Q1 | -- | -- | $0.70 | $2.39 | -$1.69 |
01/26/2021 | Q4 | -- | -- | $1.41 | $2.46 | -$1.05 |
10/26/2020 | Q3 | -- | -- | $1.26 | $2.37 | -$1.11 |
07/27/2020 | Q2 | -- | -- | $1.14 | $2.04 | -$0.90 |
04/27/2020 | Q1 | -- | -- | $1.00 | $1.99 | -$0.99 |
01/27/2020 | Q4 | -- | -- | $1.62 | $2.43 | -$0.81 |
10/23/2019 | Q3 | -- | -- | $1.57 | $2.55 | -$0.98 |
07/24/2019 | Q2 | -- | -- | $2.52 | $2.48 | $0.04 |
04/24/2019 | Q1 | -- | -- | $2.57 | $2.54 | $0.03 |
01/23/2019 | Q4 | -- | -- | $2.70 | $2.53 | $0.17 |
10/24/2018 | Q3 | -- | -- | $2.90 | $2.63 | $0.27 |
07/25/2018 | Q2 | -- | -- | $2.44 | $2.39 | $0.05 |
04/25/2018 | Q1 | -- | -- | $2.31 | $2.27 | $0.04 |
01/24/2018 | Q4 | -- | -- | $2.26 | $2.05 | $0.21 |
10/25/2017 | Q3 | -- | -- | $2.44 | $2.20 | $0.24 |
07/26/2017 | Q2 | -- | -- | $2.03 | $2.03 | $0.00 |
04/26/2017 | Q1 | -- | -- | $1.95 | $1.97 | -$0.02 |
01/25/2017 | Q4 | -- | -- | $1.98 | $1.94 | $0.04 |
10/26/2016 | Q3 | -- | -- | $1.69 | $1.54 | $0.15 |
07/20/2016 | Q2 | -- | -- | $1.41 | $1.38 | $0.03 |
04/20/2016 | Q1 | -- | -- | $1.24 | $1.27 | -$0.03 |
01/20/2016 | Q4 | -- | -- | $1.32 | $1.27 | $0.05 |
11/12/2015 | Q3 | -- | -- | $1.40 | $1.40 | -- |
F5 reported $731.1M worth of top line sales in its most recent quarter.
F5 announced earnings per share of $2.48 which represents a miss of analyst forecast a $3.11 per share.
F5 reported $590.2M that represents $10.04 per share over the last quarter.
F5's earnings are forecast to grow from $9.55 per share to $13.15 per share next year representing an increase of 52.4%.
F5's next earnings date is July 30, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.